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This comprehensive review highlights the use of microalgae for biotechnological 28 
exploitation, and discusses production of high value products, genetic engineering of 29 
microalgae, downstream processing issues and engineering of synthetic communities  30 
  3 
Abstract 31 
 32 
Microalgae are a diverse group of single-cell photosynthetic organisms that include 33 
cyanobacteria and a wide range of eukaryotic algae. A number of microalgae contain high-value 34 
compounds such as oils, colorants and polysaccharides, which are used by the food additive, oil 35 
and cosmetic industries, among others. They offer the potential for rapid growth under 36 
photoautotrophic conditions, and they can grow in a wide range of habitats. More recently, the 37 
development of genetic tools means that a number of species can be transformed and hence used 38 
as cell factories for the production of high-value chemicals or recombinant proteins. In this 39 
article we review exploitation use of microalgae with a special emphasis on genetic engineering 40 
approaches to develop cell factories, and the use of synthetic ecology approaches to maximise 41 
productivity. We discuss the success stories in these areas, the hurdles that need to be overcome, 42 
and the potential for expanding the industry in general.  43 
 44 
 45 
1. Introduction 46 
 47 
Microalgae are a large and diverse group of photosynthetic organisms ranging from prokaryotic 48 
cyanobacteria to eukaryotic algae spread across many phyla (Guiry, 2012). This diversity offers 49 
great potential that has yet to be exploited to any great extent. Microalgae are found in 50 
freshwater and marine habitats and produce half of the atmospheric oxygen on earth. The ability 51 
to grow autotrophically makes their cultivation potentially simple and cost-effective, and 52 
microalgae have attracted increasing interest as sources of natural food additives, cosmetics, 53 
animal feed additives, pigments, polysaccharides, fatty acids and biomass (Borowitzka, 2013; 54 
Hallmann, 2007; Leu and Boussiba, 2014). An important aspect of using microalgae for 55 
industrial purposes is the GRAS (generally regarded as safe) status of numerous algae. This is 56 
essential for products intended for animal or human consumption and could significantly reduce 57 
downstream processing costs. Recently, major advances in developing microalgae as biotech 58 
platforms have been made; this is especially the case from a genetic engineering perspective. 59 
Here we give an overview of state of the art engineering tools, previous successes with 60 
recombinant protein expression and advances made in engineering cyanobacteria for high value 61 
compound production. Furthermore, the largely untapped potential of algae grown in synthetic 62 
communities and the challenges associated with downstream processing of microalgae are 63 
discussed. 64 
 65 
2. High-value natural products in microalgae 66 
 67 
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Microalgae are the source of several forms of high-value compounds such as carotenoids, 68 
polyunsaturated fatty acids (PUFAs), proteins, antioxidants and pigments. Characterised by 69 
high protein and nutrient contents, some species such as Arthrospira platensis (a 70 
cyanobacterium, also known as Spirulina platensis) and Chlorella vulgaris (a green alga) are 71 
used as feed, food additives and diet supplements (Yaakob et al., 2014). In other cases specific 72 
high-value compounds are isolated from appropriate strains. 73 
 74 
Relatively few proteins have been purified from microalgae for commercial use, but Spirulina is 75 
a rich source of phycocyanin, a protein that constitutes 14% of the dry weight of this 76 
cyanobacterium (McCarty, 2007). The US Food and Drug Administration (FDA) has approved 77 
phycocyanin from Spirulina as a blue food colorant. Moreover phycocyanobilin, the 78 
tetrapyrrole chromophore of phycocyanin, manifests fluorescent properties that have been 79 
exploited for labelling of antibodies in immunofluorescence and flow cytometry. In mammalian 80 
tissues it can be enzymatically reduced to phycocyanorubin (a close homolog of bilirubin) and 81 
inhibits the activity of NADPH oxidase, thus reducing the generation of reactive oxygen 82 
species. It has been suggested that a regular intake of phycocyanobilin may provide protection 83 
against cancer and other diseases (Sørensen et al., 2013). Moreover, recent studies have proven 84 
the beneficial health effect of microalgae (Chlorella, Spirulina) by increasing natural killer cell 85 
levels and stimulating immune and anti-inflammatory system response in humans (Nielsen et 86 
al., 2010; Kwak et al., 2012). 87 
 88 
Carotenoids are important products that are extracted from microalgae, and indeed the first 89 
commercialised product derived from algae was β-carotene. It is produced in very high amounts 90 
by Dunaliella salina, a halophilic alga growing in saline habitats which makes the cultures less 91 
susceptible to contamination. What differentiates Dunaliella β-carotene from the synthetic 92 
product (present only in the form of all-trans isomer) is that it is rich in the 9-cis isomer, and a 93 
negative effect of the use of all-trans isomer, such an effect on plasma cholesterol levels and 94 
atherogenesis, has been reported from mice studies (Borowitzka, 2013; Harari et al., 2008). 95 
Another example of a carotenoid with a well-established and growing market in the 96 
nutraceutical area is astaxanthin from the freshwater green alga Haematococcus pluvialis. 97 
Astaxanthin is mainly used as a feed supplement and pigmentation source for salmon and 98 
shrimp farming, but due to its high antioxidant properties (10-fold greater than other 99 
carotenoids) and protective activities it has also many applications in the pharmaceutical and 100 
cosmetic industries. Astaxanthin has also been shown to prevent bacterial infection, vascular 101 
failure and cancer (Ambati et al., 2014). 102 
 103 
Fatty acids are the other natural components produced commercially from microalgae. Several 104 
marine algal species are rich in omega-3 long chain polyunsaturated fatty acids (LC-PUFAs), 105 
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such as docosahexaenoic acid (DHA; e.g. from Isochrysis strain T-iso and Pavlova lutheri), 106 
eicosapentaenoic acid (EPA; e.g. Nannochloropsis gaditana, Nannochloropsis oculata) and 107 
alpha-linolenic acid (e.g. Rhodomonas salina, Tetraselmis uecica). Oils from Nannochloropsis, 108 
Rhodomonas and Tetraselmis have higher antioxidant properties than fish oils, partly because of 109 
a high content of valuable carotenoids (fucoxanthin, lutein, neoxanthin, alloxantin) and 110 
polyphenols. Given the fact that intensive fishing endangers many fish species, algal oils may 111 
provide an alternative to fish oils in diets in the future (Ryckebosch et al., 2014). 112 
 113 
Other algal species such as Dunaliella salina and Botryococcus braunii can accumulate up to 114 
60% of storage lipids as triacylglycerides (TAGs), potentially making them a valuable source of 115 
oil for biodiesel production (Scott et al., 2010). Compared to plants, algae exhibit higher 116 
productivities and theoretically could give 10- to 100-fold higher yields of oil per acre, although 117 
such capacities have not yet been achieved on a commercial scale (Greenwell et al., 2010). 118 
Nevertheless, algae appear to be a potential solution to the controversial food vs. fuel problem 119 
that is associated with the use of fertile land to produce plant-derived biofuels. TAGs are not the 120 
only way in which microalgae could be exploited for biofuels. Under anaerobic conditions and 121 
sulphur depletion, some microalgae produce hydrogen gas, which could be used as an 122 
alternative to fossil fuels in the future (Melis et al., 2000; Zhang et al., 2002). Recently, Scoma 123 
et al. have attempted to produce hydrogen from Chlamydomonas reinhardtii using natural 124 
sunlight. Although successful, the overall yields did not exceed those obtained in lab-scale 125 
settings (Scoma et al., 2012) and so this technology is at an early stage. 126 
 127 
While the above compounds are well-established microalgal products with known potential, 128 
other microalgae are being studied for new compounds with useful properties. Some 129 
cyanobacteria have a poor reputation in the popular press for causing toxic blooms, because 130 
they are able to produce hepatotoxins and neurotoxins (e.g. anatoxin, jamaicadine, L-beta-N-131 
methylamino-L-alanine) (Araoz et al., 2010). However, research on cyanobacteria is undergoing 132 
a renaissance, because some identified metabolites and their derivatives have been shown to 133 
have potential as next generation antiviral (Huheihel et al., 2002), anticancer (Leao et al., 2013) 134 
and antibacterial drugs. Several of these drugs have even successfully reached phase II and III 135 
clinical trials (Dixit and Suseela, 2013). A large number of promising natural compounds are 136 
derived from filamentous marine genera such as Lyngbya, Symploca and Oscillatoria. Usually 137 
they are short peptides built from non-canonical amino acids by the hybrid polyketide synthase 138 
(PKS)/non-ribosomal peptide synthetase (NRPS) (Tan, 2013). 139 
 140 
Some of the most promising candidate anticancer agents are derivatives of dolastatin 10, a 141 
peptide originally isolated from sea hare Dolabella auricularia. The first one, TZT-1027 142 
(soblidotin) is a microtubule polymerisation inhibitor that exhibits antitumor activity in 143 
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preclinical models, manifesting stronger activity than paclitaxel (Akashi et al., 2007; Watanabe 144 
et al., 2006). Another analogue of dolastatin 10 (monomethyl auristatin E) linked to an antibody 145 
is already approved by FDA and used in therapies for patients with Hodgkin lymphoma (Deng 146 
et al., 2013). 147 
 148 
In summary, algae and cyanobacteria are an apparently under-explored source of natural high-149 
value compounds and there is a rising interest in their exploitation. Just as numerous plant 150 
secondary metabolites have been used for biotechnological and biomedical purposes, there is 151 
huge scope for the identification of correspondingly valuable compounds within the vast 152 
microalgal population. New discoveries are made regularly and new compounds and 153 
applications for industrial purposes are to be expected in the near future. 154 
 155 
3. Genetic tools in microalgae, and the development of microalgal cell factories  156 
 157 
As well as containing a range of high-value compounds, microalgae offer real potential as cell 158 
factories for the production of other compounds and proteins. With the advancement and 159 
availability of algal genome data, transformation protocols have been developed for a number of 160 
microalgae and this means that they can now be used to enhance the levels of natural high-value 161 
products, or for the expression of genes in order to produce novel products, or recombinant 162 
proteins including antibodies, hormones, vaccines and insecticidal protein at economically 163 
viable levels (Gong et al., 2011; Hallmann, 2007). To date, there have been reports of 164 
successful genetic manipulation of over 40 different microalgae species including the green 165 
algae C. reinhardtii, D. salina, C. vulgaris and H. pluvialis, and the diatoms Phaeodactylum 166 
tricornutum and Thalassiosira pseudonana (Walker et al., 2005). However, the genetic toolkits 167 
developed for C. reinhardtii and P. tricornutum are the most advanced, and both nuclear and 168 
chloroplast transformation has been achieved, so these species will be reviewed as examples. 169 
 170 
In recent years there have been rapid developments of genetic tools for microalgae in an attempt 171 
to generate more effective microalgal cell factories. Microalgae have several distinct advantages 172 
compared with plant-based production and some other bioreactor systems. Firstly, many 173 
microalgae can double their biomass in less than 24 hours, with some species such as Chlorella 174 
sorokiniana having a doubling time under optimum conditions of less than three hours (Sorokin, 175 
1967). Therefore only a short period of time is required for large-scale production compared 176 
with plants. Furthermore, the time from creation of a new transgenic line to industrial scale up 177 
can be as short as two months (Mayfield et al., 2007; Schmidt, 2004). Secondly, genes for 178 
recombinant proteins can be expressed from the nuclear or chloroplast genomes (León-Bañares 179 
et al., 2004), and eukaryotic microalgae possess post-translational modification pathways which 180 
allow glycosylated proteins to be produced and secreted out of the cell (Hempel and Maier, 181 
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2012; Lauersen et al., 2013a, 2013b). Thirdly, many microalgae can be grown either 182 
phototrophically or heterotrophically in enclosed photobioreactors, preventing transgenes from 183 
escaping into the environment. This is a particular concern for transgenic plants where 184 
transgenic DNA might spread to soil bacteria or to related plant species by means of pollen 185 
transfer (Gong et al., 2011). Prior to introducing the desired gene into an algal genome, a few 186 
fundamental factors such as DNA delivery method, selection method and control of gene 187 
expression have to be taken into account. 188 
 189 
3.1. DNA Delivery Method.  190 
A variety of different methods have been employed for delivering transgenes into algal cells 191 
(Table 1), and the method of choice is very much determined by the cell size and nature of the 192 
cell wall of the chosen algal species (Stevens and Purton, 1997). The first demonstrations of 193 
stable transformation of an alga involved the bombardment of C. reinhardtii cells with DNA-194 
coated microprojectiles (so-called biolistics) and proved successful for the delivery of DNA into 195 
both the chloroplast (Boynton et al., 1988) and nucleus (Debuchy et al., 1989). Biolistics was 196 
also used to transform the mitochondrial genome of C. reinhardtii (Randolph-Anderson et al., 197 
1993). 198 
 199 
Subsequently, the nuclear genome of C. reinhardtii has been genetically transformed using 200 
other delivery methods including agitation in the presence of glass beads or silicon carbide 201 
whiskers, electroporation, Agrobacterium-mediated transformation, and, more recently, 202 
positively-charged aminoclay nanoparticles (Brown et al., 1991; Dunahay, 1993; Kim et al., 203 
2014; Kindle, 1990; Kumar et al., 2004). Unlike biolistics or electroporation, methods using 204 
glass beads, silicon carbide whiskers or Agrobacterium do not involve any specialised 205 
equipment and can be done in any laboratory at low cost, although silicon carbide whiskers can 206 
be difficult to obtain and may potentially be a health hazard (León-Bañares et al., 2004). The 207 
glass bead method remains popular, and has also been employed for chloroplast transformation 208 
as a simple alternative to biolistics (Economou et al., 2014; Kindle et al., 1991). For nuclear 209 
transformation by electroporation, cell wall-less strains (either mutants or cells treated with 210 
autolysin) are normally used (Brown et al., 1991; Shimogawara et al., 1998). However, C. 211 
reinhardtii with an intact cell wall was recently transformed using a series of multi-212 
electroporation pulses (Yamano et al., 2013). The cheaper Agrobacterium-mediated gene 213 
transfer technique can also be used with walled strains and has been reported to give high 214 
transformation frequency compared to glass bead transformation (Kumar et al., 2004), and this 215 
can be increased further by inducing the Agrobacterium prior to infection using acetosyringone 216 
and glycine betaine (Pratheesh et al., 2014).  217 
 218 
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Nuclear transformation using aminoclay nanoparticles (positively charged nanoparticles based 219 
on 3-aminopropyl-functionalized magnesium phyllosilicate) is still new, but it has also been 220 
reported to give high transformation rates, and again this simple method can be used with wild-221 
type strains possessing a cell wall (Kim et al., 2014). This method might have general 222 
applicability to other algal species that have traditionally been transformed using particle 223 
bombardment (Walker et al., 2005) since the aminoclay nanoparticles (45 nm) are several 224 
orders of magnitude smaller than the gold particles (1 μm to 3 μm) used in the bombardment 225 
The size of particles is an important factor, because smaller particles increase the chance of cell 226 
wall penetration and genome integration (Kim et al., 2014).  227 
 228 
The nuclear genome of the diatom P. tricornutum is most commonly transformed via particle 229 
bombardment (Apt et al., 1996; Falciatore et al., 1999). Diatoms are generally quite difficult to 230 
transform due to challenges such as controlling and manipulating their life cycles, as well as 231 
penetrating their rigid cells walls (Falciatore et al., 1999). Nonetheless, recently the P. 232 
tricornutum nuclear genome was successfully transformed by electroporation (Miyahara et al., 233 
2013; Zhang and Hu, 2014). More remarkable, given the four membranes that surround a 234 
diatom chloroplast, is a recent demonstration that electroporation can be used to deliver DNA 235 
into the chloroplast genome (Xie et al., 2014). 236 
 237 
Chloroplast genome engineering is particularly attractive given the ability to target transgenes 238 
into specific, predetermined loci via homologous recombination, and the high levels of 239 
expression that can be achieved. To date, chloroplast transformation by biolistics has been 240 
reported for five other algal species: Dunaliella tertiolecta, Euglena gracilis, Haematococcus 241 
pluvialis, Porphyridium sp. and Tetraselmis cordiformis (Cui et al., 2014; Purton et al., 2013).  242 
 243 
3.2.  Selectable Markers, Reporter Genes and Promoters 244 
Different types of selectable marker and reporter genes can be used in identifying putative 245 
transformants from the population of untransformed cells (Table 2). Endogenous selectable 246 
markers for nuclear transformation of the haploid C. reinhardtii allow the rescue of auxotrophic 247 
or non-photosynthetic mutants with examples for nuclear transformation being ARG7, NIT1 and 248 
OEE1 that allow rescue of recessive mutants defective in arginine biosynthesis, nitrate 249 
metabolism and photosynthesis, respectively (Stevens and Purton, 1997). A wide range of 250 
dominant markers are commonly used in C. reinhardtii and confer resistance to various 251 
antibiotics or herbicides, as detailed in Table 2. For chloroplast transformation, several 252 
dominant markers (e.g. aadA and aphA6) have been developed (Table 2). In addition, 253 
endogenous chloroplast genes have been used as selectable markers for phototrophic rescue of 254 
the corresponding chloroplast mutant: for example the atpB gene rescues an atpB mutant 255 
defective in the ATP synthase. The use of phototrophic markers is not possible for nuclear or 256 
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chloroplast transformation of wild-type P. tricornutum since this diatom is an obligate 257 
phototroph. However, an engineered strain expressing a transgene encoding a glucose 258 
transporter has been described that is capable of heterotrophic growth on the sugar (Zaslavskaia 259 
et al. 2001), and this potentially could be used to develop non-phototrophic recipient strains.  260 
Reporter genes based on fluorescent proteins, luciferases or colorimetric enzymes have been 261 
developed for both the nucleus and chloroplast (Table 2), with the key to good expression of 262 
such transgenes being the use of synthetic genes that are codon-optimised for expression in the 263 
algal host (Fuhrmann et al., 1999; Zaslavskaia et al., 2000; Purton et al. 2013).  264 
 265 
For transgene expression in the nucleus or the chloroplast, promoters and untranslated regions 266 
(UTRs) from highly expressed endogenous genes are typically used. For nuclear expression 267 
these include genes for subunits of the photosynthetic complexes, ribulose bisphosphate 268 
carboxylase or components of the light-harvesting apparatus (Walker et al. 2005), and for 269 
chloroplast expression, genes for core photosynthetic subunits such as atpA, psbA, psaA and 270 
psbD (Purton, 2007). However, such chloroplast genes are typically under feedback control via 271 
trans-acting factors that bind to the 5’ untranslated region (UTR). Recently, (Specht and 272 
Mayfield, 2013) have shown that re-engineering these 5’UTRs can overcome such control and 273 
result in elevated levels of transgene expression. 274 
 275 
With the advancement of microalgal biotechnology, many tools and techniques for the genetic 276 
manipulation of microalgae have been developed. However, nuclear transformation still faces 277 
problems such as poor transgene integration, codon bias, positional effects and gene silencing 278 
which can lead to poor or unstable transgene expression. Moreover, there are still limited 279 
molecular genetic tools for many of the microalgal species that have high commercial value. 280 
Chloroplast transformation is a promising strategy for precise engineering and high-level 281 
expression of transgenes, but its application is still largely limited to C. reinhardtii, and again 282 
there is a pressing need to develop reliable methods for commercial species. Hence, more work 283 
has to be carried out so that microalgae can be exploited as light-driven bioreactors in the future.  284 
 285 
4. Production of Recombinant Proteins in Microalgae 286 
 287 
Several previous studies have shown that microalgae are promising production platforms for 288 
recombinant proteins. Major successes and recent advances in recombinant protein production 289 
are summarised in the following. 290 
 291 
Monoclonal antibodies are complex molecules used to treat several human diseases. To date 292 
most antibodies are produced in mammalian cells due to their ability to carry out post-293 
translational modifications, particularly glycosylation and disulphide bond formation. Recently, 294 
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efforts have also been directed towards producing them in bacteria and yeast (Spadiut et al., 295 
2014). The first expression of a functional antibody in microalgae was achieved in the 296 
chloroplast of C. reinhardtii. A large single chain antibody directed against the herpes simplex 297 
virus (HSV) glycoprotein D was successfully expressed in this green alga. The genetic construct 298 
was integrated into the chloroplast genome via homologous recombination and expression was 299 
driven by atpA or rbcL promoters and 5’ UTRs. The antibodies were shown to accumulate as 300 
soluble proteins in the chloroplast and could bind to HSV proteins in ELISA experiments. 301 
Heavy and light chains assembled by forming disulphide bonds, however, no other post-302 
translational modifications were detected (Mayfield et al., 2003). In another study, a fully 303 
functional monoclonal antibody against anthrax protective antigen 83 (PA83) was expressed in 304 
the C. reinhardtii chloroplast. Separate constructs for the heavy and light chain were introduced 305 
and the antibody was shown to assemble spontaneously by forming the necessary 16 disulphide 306 
bonds (Tran et al., 2009).  307 
 308 
The production of antibodies in microalgae is, however, not restricted to Chlamydomonas. A 309 
monoclonal antibody was also successfully expressed in the endoplasmic reticulum (ER) of the 310 
diatom P. tricornutum. It was directed against the Hepatitis B virus surface protein and 311 
accumulated to 8.7 % of total soluble protein. Heavy and light chains, retained in the ER by 312 
DDEL retention peptides, were shown to assemble into complete antibodies and were 313 
glycosylated (Hempel et al., 2011). When the same group omitted the ER retention signal from 314 
their constructs, functional antibodies were efficiently secreted and accumulated in the culture 315 
medium in an active form (Hempel and Maier, 2012). 316 
 317 
Another group of valuable therapeutics are immunotoxins, which are most commonly used in 318 
the treatment of cancer. Immunotoxins are antibodies coupled to eukaryotic toxins and are 319 
difficult to produce in both prokaryotic and eukaryotic hosts. Tran et al. (2012) were able to 320 
show that fully functional immunotoxins can be expressed in algal chloroplasts. An antibody 321 
directed against the B-cell surface epitope CD22 was genetically linked to Exotoxin A from the 322 
human pathogenic bacterium Pseudomonas aeruginosa and expressed in the chloroplast of C. 323 
reinhardtii. It was shown that the immunotoxins were enzymatically active, bound specifically 324 
to CD22 on B-cells and inhibited cell proliferation in vitro. Tests in mouse xenograft models 325 
showed reduced tumour progression (Tran et al., 2012). In another study the successful 326 
expression of an immunotoxin comprising of an antibody recognizing B-cell CD22 coupled to 327 
gelonine, a ribosome inhibiting protein, in the C. reinhardtii chloroplast was demonstrated. The 328 
immunotoxin was shown to inhibit the survival of two B-cell lymphoma lines (Ramos and CA-329 
46) while leaving Jurkat T-cells intact, thereby proving their specificity (Tran et al., 2013). 330 
 331 
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Several vaccine antigens have been produced in the chloroplast of C. reinhardtii (Demurtas et 332 
al., 2013; He et al., 2007; Sun et al., 2003). The GRAS status of the alga makes the production 333 
of antigens without costly purification from residual toxins or impurities attractive and could 334 
even be exploited for oral delivery of vaccines. An algal produced Staphylococcus aureus 335 
vaccine was shown to protect orally vaccinated mice against sub-lethal and lethal doses of S. 336 
aureus infection (Dreesen et al., 2010). Malaria transmission blocking vaccines were also 337 
successfully expressed in the C. reinhardtii chloroplast (Gregory et al., 2012; Gregory et al., 338 
2013; Jones et al., 2013). In addition, Bayne et al. showed that it is possible to produce 339 
influenza haemagglutinin (HA) in the heterotrophic alga Schizochytrium sp. thereby presenting 340 
an alternative to current egg-based vaccine production platforms (Bayne et al., 2013). 341 
 342 
Other proteins expressed in microalgae include mammary-associated serum amyloid (M-SAA) 343 
which could be used as viral and bacterial prophylaxis in new born mammals (Manuell et al., 344 
2007); domains 10 and 14 of human fibronectin which have potential as antibody mimics; 345 
proinsulin and vascular endothelial growth factor, as well as the high mobility group protein B1 346 
involved in wound healing (Rasala et al., 2010). Furthermore, a human selenoprotein, Sep15 347 
(Hou et al., 2013) and antitoxins against botulinum neurotoxin have been successfully produced 348 
(Barrera et al., 2014). 349 
 350 
Further efforts to develop microalgae as a production platform have been made. Other than the 351 
therapeutic proteins mentioned, several enzymes have been successfully produced in C. 352 
reinhardtii. The industrially relevant Xylanase 1 was expressed in the nucleus of C. reinhardtii 353 
both in a soluble and secreted form (Rasala et al., 2012). The first membrane-bound enzyme 354 
expressed in the C. reinhardtii chloroplast was CYP79A1 from Sorghum bicolor. It was shown 355 
to be active and produced p-hydroxyphenylacetaldoxime, the precursor for a plant natural 356 
product, from endogenous tyrosine (Gangl et al., 2014). In another study, a bifunctional 357 
diterpene synthase was expressed in the chloroplast of C. reinhardtii, and is the largest 358 
recombinant protein expressed to date. This synthase is of interest for exploring the potential of 359 
terpenoid production in microalgae (Zedler et al., 2014; see section 5 for details). 360 
 361 
Despite the huge variety of recombinants successfully produced in algae to date, only one report 362 
exists of transferring recombinant protein production to a larger scale. A milk Amyloid A-363 
producing strain of C. reinhardtii was grown in three 100 L bags in a greenhouse setting and the 364 
maximum rate of MAA production achieved was 0.051 ± 0.016 g/L/day (Gimpel et al., 2014). 365 
The lack of other examples shows that the knowledge transfer from the lab scale to industrially 366 
relevant growth conditions for recombinant protein production in microalgae is still not 367 
established. 368 
 369 
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5. Metabolic engineering of microalgae to produce other high value compounds 370 
 371 
Microalgae offer additional potential as light-driven cell factories for the production of novel 372 
metabolites. Plant secondary products are one of the most important forms of target compound. 373 
Plants are a source of a broad spectrum of diverse bioactive compounds, also known as 374 
secondary or specialised metabolites. Often their biosynthesis is restricted to specific 375 
developmental stages, tissues or even cells and they can be involved in many processes 376 
important for plant growth and survival, such as protection from pathogens or herbivores, 377 
attraction of pollinators and adaptation to environmental stress. A large number of specialised 378 
metabolites are now used by the pharmaceutical, chemical and food industries, and 379 
approximately 50% of all approved medicines including anticancer drugs are of natural origin 380 
(Dai et al., 2014; Lassen et al., 2014a). 381 
 382 
Many of these plant-derived compounds can be produced by chemical synthesis, but in some 383 
cases due to complexity of their structure they require difficult multistep regio- and stereo-384 
specific reactions, therefore overall yields can be very low. This applies particularly to the 385 
synthesis of terpenoids – a particularly large, complex and important family of plant secondary 386 
metabolites. One solution to this problem can be extraction from the plant source, but if a 387 
product is accumulated in scarce amounts, the result may not be economically viable. An 388 
example is paclitaxel, a cytostatic drug known under the commercial name Taxol. Its 389 
accumulation in Taxus baccata depends on the maturity of the tree and ranges from 0.064 g (27 390 
year old tree) to 8.038 g (136 year old tree) per tree (Nadeem et al., 2002), whereas chemical 391 
synthesis is complicated and requires 40 different steps (Nicolaou et al., 1994). 392 
 393 
5.1 Towards engineering metabolic pathways 394 
An alternative method for production of high-value chemicals is to use synthetic biology or 395 
metabolic engineering tools. Both terms are often used interchangeably, however there are 396 
significant differences between the two fields. Synthetic biology is more about designing and 397 
using defined synthetic DNA parts (biobricks), constructing genetic circuits and molecular 398 
switches to control the expression and metabolism, whereas metabolic engineering is a broader 399 
term involving protein engineering and pathway optimisation in order to improve production 400 
yields of desired product (Stephanopoulos, 2012). Nonetheless, both are understood as 401 
transferring biosynthetic pathways from one organism to another (or combining pathways from 402 
different organisms). 403 
 404 
In order to produce some specialized high-value compounds such as terpenoids, it is often 405 
necessary to perform highly specific and complex enzymatic reactions, which can be catalysed 406 
by cytochromes P450 (P450s). For example, biosynthesis of both artemisinin and paclitaxel 407 
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requires the involvement of P450s. Unfortunately the expression of plant P450s in E. coli and S. 408 
cerevisiae is not always simple due to special requirements for post-translational modification 409 
and protein localisation, and in consequence plant P450s are often inactive upon expression in 410 
these hosts (Chemler and Koffas, 2008). 411 
 412 
P450s are monooxygenases performing stereospecific hydroxylations and they are anchored in 413 
the plant endoplasmic reticulum (ER). In order to function they need to be powered by single 414 
electron transfers from NADPH-dependent cytochrome P450 reductase (CPR). The expression 415 
level of these proteins is relatively low and the activity is often limited by NADPH and 416 
substrate pool (Jensen et al., 2011). It has been demonstrated that these energy-consuming 417 
reactions can be bypassed by relocating P450-dependent metabolic pathways to the thylakoid 418 
membranes of tobacco chloroplasts, where the reducing power generated by photosystem I 419 
(PSI) in the form of reduced ferredoxin (Fd) is a cheap and essentially unlimited source of 420 
electrons for the P450s (Nielsen et al., 2013) (Fig. 1). More recently, it has been shown that a 421 
P450 can be expressed in the chloroplasts of transgenic C. reinhardtii and it was furthermore 422 
shown that the enzyme was targeted into the chloroplast membranes and highly active (Gangl et 423 
al., 2014). This strongly suggests that it will be possible to produce pharmacologically 424 
important terpenoids not only in plant chloroplasts (Bock and Warzecha, 2010), but also in 425 
microalgal chloroplasts. 426 
 427 
5.2. Cyanobacteria as a tool for synthetic biology 428 
During the last decade, cyanobacteria have been gaining renewed interest as a chassis for 429 
metabolic engineering and synthetic biology approaches. Currently many efforts are being 430 
undertaken to use genetically modified cyanobacteria as a production platform for biofuels such 431 
as isoprene (Zhou and Li, 2010), bioplastics like polyhydroxybutyrate (Wang et al., 2013) and 432 
polylactic acid (Angermayr et al., 2014), fatty acids (Ruffing, 2014), ethylene (Guerrero et al., 433 
2012; Ungerer et al, 2012) and sugars (Jacobsen and Frigaard, 2014). In many cases reported 434 
yields are not yet satisfactory, however, the ability to perform photosynthesis and the idea of 435 
converting sunlight and carbon dioxide into high value chemicals are undoubtedly attractive. 436 
 437 
As indicated above, expression of foreign pathways involving P450s in E. coli often causes 438 
problems and is ineffective, due to difficulties with proper folding, posttranslational 439 
modifications and targeting to the membranes. Unlike most native bacterial P450 enzymes that 440 
are soluble, cyanobacterial P450s are membrane bound, exactly like plant P450s (Robert et al., 441 
2010). All the above considerations indicate that cyanobacteria and eukaryotic microalgae can 442 
be suitable candidates for expression of foreign P450s. 443 
 444 
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Expression of p-coumarate-3-hydroxylase from Arabidopsis thaliana in the cyanobacterium 445 
Synechococcus sp. PCC 6803 for the production of caffeic acid was the first reported successful 446 
expression of a plant cytochrome P450 in cyanobacteria (Xue et al., 2014). Further genetic 447 
strain modifications resulted in a 25-fold increase of production rate of p-coumaric acid (a 448 
precursor for caffeic acid) giving yields of 82.6 mg/L secreted to the media (Xue et al., 2014). 449 
Another example of stable expression of a P450 enzyme (CYP79A1 from the dhurrin pathway) 450 
in Synechococcus sp. PCC 7002, and direction of the protein to the thylakoid membranes by 451 
fusing the protein with the PsaM subunit of PSI has recently been reported (Lassen et al., 2014). 452 
Successful heterologous expression of the mevalonic acid (MVA) pathway in Synechocystis sp. 453 
PCC 6803 (Bentley et al., 2014) and production of β-phellandrene (Bentley et al., 2013) also 454 
opens up the opportunity to express terpenoid biosynthetic pathways in cyanobacteria. 455 
Moreover, excretion of produced metabolites into the growth media (Lassen et al., 2014; Xue et 456 
al., 2014) suggests that cyanobacteria have an unexplored potential as good platforms for 457 
metabolic engineering. Overall, it is clear that these organisms have potential as production 458 
hosts but it is fair to say that improvements are required before they can attain mainstream 459 
status as production chassis. 460 
 461 
6. Techniques to engineer algal communities 462 
 463 
In their natural environment, algae live intimately with many other organisms. These 464 
communities exhibit complex interactions including metabolite exchange, cell aggregation and 465 
biofilm formation (Jagmann and Philipp, 2014). For example, at least half of all algal species 466 
require an exogenous supply of vitamin B12, and bacteria can be a source for this co-factor in 467 
return for a carbon source, thus forming a tightly regulated symbiosis (Croft et al., 2005; 468 
Kazamia et al., 2012). Further examples include the symbiosis between a unicellular 469 
prymnesiophyte alga and a cyanobacterium (UCYN-A) with the former providing a carbon 470 
source in return for fixed nitrogen (Thompson et al., 2012), and the dynamic symbiosis between 471 
the haptophyte alga Emiliania huxleyi and the bacterium Phaeobacter gallaeciensis BS107, 472 
which can be mutualistic or parasitic according to environmental conditions (Seyedsayamdost et 473 
al., 2011).  474 
 475 
In contrast, algal biotechnology has traditionally involved large-scale cultivation of axenic 476 
cultures (Day et al., 2012; Scott et al., 2010). This difference has been widely recognised and 477 
consequently there are many reviews outlining the potential benefits of using consortia in algal 478 
biotechnology. The main advantages proposed include an increase in algal productivity (accrued 479 
biomass) of mixed cultures compared to axenic cultures, enhanced crop protection from 480 
pathogens and pests due to the competitive exclusion principle, reduction of energy inputs, 481 
increased stability of the crop to include population control and resilience to environment 482 
  15 
perturbations, and finally the division of labour between consortium members leading to 483 
increased ability to engineer complex and broader metabolic pathways (Table 3) (Jagmann and 484 
Philipp, 2014; Kazamia et al., 2014; Nalley et al., 2014; Ortiz-Marquez et al., 2013; Pandhal 485 
and Noirel, 2014; Smith and Crews, 2014). 486 
 487 
Although the proposed benefits of creating algal communities are great, engineering the 488 
communities in practice is likely to be complex. We therefore focus on examples where 489 
engineering of efficient algal communities has been shown to be effective.  490 
 491 
6.1. Genetic engineering for symbiosis 492 
Genetic manipulation can be used to engineer organisms to interact in a clearly defined way by 493 
the trading of metabolites. Examples of this include engineering the nitrogen-fixing bacterium 494 
Azotobacter vinelandii to secrete fixed nitrogen into the growth media, replacing the need for 495 
addition of synthetic nitrogen inputs for algal growth (Ortiz-Marquez et al., 2014; Ortiz-496 
Marquez et al., 2012), and the engineering of the cyanobacterium Synechocystis sp. PCC 6803 497 
to secrete a carbon source for Escherichia coli which it can utilise to produce low- to high-value 498 
compounds (Niederholtmeyer et al., 2010). The benefits of using one organism to provide 499 
nutrients for another include the potential to lower production costs (nutrient inputs and energy 500 
consumption) and reduce the carbon footprint of the process. However, creating these 501 
communities may require considerable investment of time and resources, limiting the size to a 502 
small number of interactions therefore limiting the benefit of the competitive exclusion 503 
principle (Table 3). Given the limited ability to exclude contaminants, this strategy, if applied 504 
on its own, would be best suited for contained cultures (with low risk of contamination) for 505 
production of high-value products in contrast to cultures exposed to the environment (for low-506 
value product) where contaminants will easily occupy niches and even take advantage of the 507 
engineered community. 508 
 509 
6.2. Screening symbioses 510 
Screening of naturally developing populations can offer a simpler method of identifying 511 
mutually beneficial symbioses from a large number of organisms. For example, Do Nascimento 512 
et al. showed an increase of up to 30% in chlorophyll, biomass and lipid accumulation in the 513 
oleaginous microalga Ankistrodesmus sp. strain SP2-15 when co-cultured with the bacterium 514 
Rhizobium strain 10II (Do Nascimento et al., 2013). The positive interaction was identified by 515 
subculturing non-axenic algal cultures (absent of organic carbon) for three years, which was 516 
followed by the isolation of bacterial strains able to utilise carbon exudates from the algal 517 
strains. The bacteria were then screened for induction of positive growth effects on various algal 518 
strains via growth curves. Le Chevanton et al. used a similar approach where bacteria were 519 
isolated from algal cultures (Le Chevanton et al., 2013). However, the cultures were initially 520 
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screened with a high-throughput optical technique to identify interactions that gave the highest 521 
chlorophyll a fluorescence. Le Chevanton et al. thus identified two bacterial strains enhancing 522 
biomass accumulation and nitrogen provision for Dunaliella sp. The final example given here 523 
highlights the importance of screening a diverse range of organisms for symbiosis. Lorincz et 524 
al. serendipitously created an artificial tripartite consortium based on the known bipartite 525 
symbiosis involving Chlamydomonas reinhardtii (alga) trading carbon to Azotobacter 526 
vinelandii (bacterium) in exchange for nitrogen. Alternaria infectoria (fungus) had 527 
spontaneously contaminated the co-culture, which led to a positive growth effect by providing 528 
amino acids (in particular cystathionine) to the consortium (Lorincz et al., 2010). Analysis of 529 
naturally developing populations is therefore advantageous in its potential for screening of a 530 
large range of interactions. However, significant investment in time, materials and manpower 531 
may be required for success.  532 
 533 
6.3. Environmental selection for symbiosis 534 
A novel approach to form communities is through manipulation of the environmental conditions 535 
to force organisms to form symbioses. For example Hom and Murray (2014) created an obligate 536 
mutualism between the yeast Saccharomyces cerevisiae and C. reinhardtii by testing a range of 537 
different conditions to identify those that allowed both organisms to grow. Under the successful 538 
conditions, S. cerevisiae provided carbon dioxide by metabolising glucose and in return C. 539 
reinhardtii provided ammonia by metabolising nitrite. The authors reproduced this mutualism 540 
with many additional algal and yeast species, which gives a sense of optimism about applying 541 
this technique to a range of other organisms (Hom and Murray, 2014). Similarly Ortiz-Marquez 542 
and colleagues created an artificial symbiosis between a strain of Azotobacter vinelandii 543 
engineered to secrete fixed nitrogen (ammonium) and the alga Chlorella sorokiniana by co-544 
culturing the species in nitrogen- and carbon-deficient media (Ortiz-Marquez et al., 2012). An 545 
important similarity between these two examples was the requirement of a solid support for the 546 
symbiosis to occur (i.e. a lack of agitation or shaking), outlining the importance of cell-cell 547 
proximity and spatial structure. It should be noted that this approach is new and only a few 548 
positive examples have been reported, so it remains to be seen how widely the approach can be 549 
applied. It also remains to be seen how robust symbioses generated in this way will be. 550 
 551 
6.4. Trait-based engineering  552 
Trait-based engineering is the creation of communities by organisms with unique but 553 
complementary growth requirements. This is based on the principle of resource-use 554 
complementarity, which allows, in principle, individuals to cohabit and lead to an increase in 555 
productivity. Examples of trait-based complementarity include the co-culturing of algal species 556 
with varying accessory light harvesting pigments maximising the utility of the visible light 557 
spectrum (Kazamia et al., 2014; Nalley et al., 2014). Trait-based engineering could be applied 558 
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to make use of the varying temperatures that occur during a 24-hour cycle as well as seasonal 559 
fluctuations, by co-culturing organisms that optimally grow at a range of temperatures, such as 560 
Detonula confervacea with a temperature optimum of 11
0
C to Chlorella pyrenoidosa, with a 561 
temperature optimum of 40
0
C (Eppley, 1985; Myers, 1984). Another feature that could be 562 
considered in this context is the introduction of species that control organisms such as 563 
zooplankton, which are known for their predation on algal species. Kazamia et al. and Nalley et 564 
al. outlined the use of fish as a means to control zooplankton (Kazamia et al., 2014; Nalley et 565 
al., 2014). Trait-based engineering has particular benefits for open-raceway production, where 566 
algal species are exposed to fluctuating environmental conditions. However, this approach will 567 
require a thorough understanding of the surrounding environment of the raceway pond to be 568 
able to handpick organisms for optimal community growth.  569 
 570 
6.5. Directed evolution 571 
Another approach is to take advantage of artificial selection as a means of creating efficient co-572 
cultures. Selecting for the ability of organisms to work together over many generations may be 573 
an efficient and productive means of achieving certain traits from mixed communities. This 574 
approach has been applied to fermentation, anaerobic digestion, bioremediation, and the 575 
production of polyhydroxyalkanoate and polyphosphates (Johnson et al., 2009; Sabra et al., 576 
2010; Serafim et al., 2008; Zeng et al., 2003). Mooij et al. (2013) used this method to select for 577 
carbon storage molecules in the form of starch and lipids in algae. Algal inocula were taken 578 
from several different surface waters and cultured in a carbon dioxide-rich light period (nitrogen 579 
absent) and then a nitrogen-rich dark period. Cycling between these two conditions over many 580 
generations selected for organisms able to produce energy storage compounds (starch/lipids) to 581 
power nitrogen assimilation in the dark periods (Mooij et al., 2013). This particular example, 582 
due to the controlled environmental conditions (nitrogen cycling), may be best utilised with 583 
photobioreactors. However, directed evolution could be applied for production of algae in open 584 
raceway ponds for the selection of resistance to extreme conditions such as high pH or salt 585 
concentrations as applied to the production of Arthrospira sp. and Dunaliella salina 586 
respectively. 587 
 588 
In summary, metabolic engineering has the advantages of precisely engineering metabolite 589 
trading as well as the ability to fine tune population dynamics (Kerner et al., 2012; You et al., 590 
2004). However, it is labour intensive as a way of creating symbiotic interactions and obtaining 591 
regulatory approval for genetically modified organisms may prove a barrier. The metabolic 592 
engineering approach is further limited to organisms whose genomes are readily manipulated. 593 
Screening and environmental selection for symbiosis has the advantage of using a potentially 594 
large range of organisms to form symbioses, and trait-based engineering and directed evolution 595 
approaches offer the potential to create highly complex communities with improved 596 
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productivity. However, these techniques are in their infancy and further evidence of their 597 
efficacy is required.  598 
 599 
Algal community research has made great progress in recent years and a number of additional 600 
technologies will be utilised alongside the engineering approaches discussed above. Some of 601 
these emerging technologies include the monitoring of algal populations through the use of 602 
qPCR; crop protection using traditional chemicals such as pesticides and herbicides (McBride et 603 
al., 2014); the highly parallel screening of beneficial and novel microbial symbiotic interactions 604 
through the use of microdroplet technology (Park et al., 2011); development of online 605 
databanks or libraries detailing functional traits of bacteria and algae so communities can be 606 
designed for optimum trait functionality (Guiry et al., 2014); and accurate modelling of 607 
communities to help predict environments that induce and stabilise microbial interactions 608 
(Grant et al., 2014; Kim et al., 2008; Klitgord and Segre, 2010). 609 
 610 
7. Downstream processing of microalgal products 611 
 612 
As described above, microalgae are light-driven cell factories that can produce a wide spectrum 613 
of natural products, or which can be engineered to produce diverse high-value compounds. 614 
Extraction and purification of these products are critical processes that can contribute to up to 615 
60% of the total production cost (Molina Grima et al., 2003). Research to date has focused on 616 
developing methods for downstream processing of algal biomass and for oil extraction and 617 
biofuel production. Many have reviewed downstream processing for biofuel production from 618 
different algae including Chlorella, Dunaliella, Nannochloris, Nannochloropsis, Porphyridium, 619 
Schizochytrium and Tetraselmis (Ahmad et al., 2014; Chen et al., 2011; Halim et al., 2012; Kim 620 
et al., 2013; Lee et al., 2012; Mata et al., 2010; Pragya et al., 2013; Rawat et al., 2013; Rios et 621 
al., 2013). In this section, we review the common steps for processing microalgae in order to 622 
prepare biofuels, recombinant proteins and other high-value products. 623 
 624 
7.1 Downstream processing methods for biofuels production  625 
Typically, downstream processing of microalgae used for the production of biodiesel consists of 626 
harvesting in a two-step operation in order to separate the biomass from the culture media using 627 
solid-liquid separation technologies. The first step is bulk harvesting where the biomass is 628 
concentrated by flocculation, flotation or gravity sedimentation reaching up to 7% total solids; 629 
the second step is thickening where the biomass slurry is concentrated into a paste by more 630 
energy-intensive processes like centrifugation or filtration (Brennan and Owende, 2010). Such 631 
technologies are chosen according to the characteristics of the microalga species and the nature 632 
and quality of the final product (Amaro et al., 2011), however, they are limited in their abilities 633 
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to separate biomass from the media and the operating cost that can fluctuate between 20 and 634 
30% of the total production cost (Gudin and Therpenier, 1986). 635 
 636 
From this point, the harvested biomass paste can undergo two different pre-treatments 637 
depending on the final product requirements, the so-called dry and wet route. The dry route, 638 
which involves technologies such as spray drying, drum drying, freeze-drying or sun drying, is 639 
the preferred method to obtain dry biomass as it offers high extraction yields, albeit with high 640 
costs and energy use (e.g. harvesting and drying combined with extraction cost is 50% of the 641 
total production cost (Pragya et al., 2013)). 642 
 643 
An alternative to the dry route is the wet route, in which wet biomass needs to be disrupted first 644 
to release the intracellular products. Cell wall composition plays an important role in this route; 645 
cell walls from microalgae are typically a thick and rigid matrix of polysaccharides and 646 
glycoproteins that require costly downstream processing steps during the production of bio-647 
products (Kim et al., 2013). For example, Haematococcus pluvialis possesses a thick cell wall 648 
that makes this alga highly resistant to chemical and physical disruption, thus significantly 649 
increasing astaxanthin production costs (Hagen et al., 2002). The unit operations for the wet 650 
route can be: mechanical (ultra-sonication, high pressure homogenisation, microwave, bead 651 
beating, and electroporation); chemical (acids, alkalis and organic solvents); biological 652 
(enzymes), or osmotic shock. Selection of methods depends again on the biomass 653 
characteristics. Assessment of the dry and wet routes have demonstrated that both have a 654 
positive energy balance for production of biofuels. This evidence also shows that the wet route 655 
has more potential for high valuable biofuels whereas the dry route seems more attractive for 656 
short term biofuel productions (Xu et al., 2011). Whether the biomass goes into the dry or wet 657 
route, the physical state of the output is a dried biomass or disrupted concentrate; this stream is 658 
processed for lipid extraction. Different methods are available including: (i). Organic solvents: 659 
algal oil can be recovered by using solvent such as chloroform, methanol, benzene, diethyl ether 660 
and n-hexane. Other metabolites such as -carotene and astaxanthin are also extracted by 661 
solvents (Molina Grima et al., 2003). However, solvent extraction can result in high toxicity if 662 
the product is used for animal or human consumption. (ii). Supercritical fluid extraction: this is 663 
a green technology based on CO2 at supercritical conditions used as a non-toxic extracting 664 
solvent in order to separate the lipids from matrix (dried biomass or disrupted concentrate). It 665 
has been applied to extract lipids and other high valuable compounds from algae, however, the 666 
operational cost is high (Mendes et al., 1995; Thana et al., 2008). 667 
 668 
7.2. Strategies to facilitate downstream processing of recombinant protein produced in 669 
microalgae 670 
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The potential of C. reinhardtii to produce recombinant proteins for industrial, nutritional, and 671 
medical uses has been discussed above, but it is notable that hardly any reports have described 672 
large scale production or recovery of target proteins. Moreover, downstream processing of 673 
engineered microalgae is largely based on laboratory scale techniques. More than 30 proteins 674 
with biotechnological applications have been expressed in Chlamydomonas (Rasala and 675 
Mayfield, 2014) including a number that have been expressed in the chloroplast. Although the 676 
chloroplast has been shown to be a robust platform for commercial production of proteins, it has 677 
some limitations as chloroplast-expressed proteins cannot be secreted, thus, cells must be 678 
processed after cultivation to recover and purify the product. Regardless of the nature of the bio-679 
product produced in the microalgae, downstream processing follows the same route as in 680 
biofuels; therefore the operations to recover high value products that require high purity 681 
(recombinant proteins, pigments, carotenoids, PUFAs, terpenoids, etc.) include harvesting, cell 682 
disruption (if the compound is intracellular) and purification. Figure 2 illustrates the recovery 683 
and purification process of recombinant proteins produced in microalgae.  684 
 685 
Since recombinant protein production in Chlamydomonas is largely limited to small-scale 686 
cultivation, the current harvesting is mainly done by conventional centrifugation. Harvested 687 
biomass can be processed using the approach of dry and wet routes. For the dry route, the 688 
drying biomass has potential in the production of edible vaccines and enzymes; research 689 
suggests that dry algal extract is an ideal vehicle for oral delivery of vaccines and enzymes as 690 
the cell wall protects the antigens and enzymes (Yoon et al., 2011). Production of vaccines that 691 
can be administrated orally is benefited by the effectiveness of freeze-drying to preserve 692 
antigen-expressing Chlamydomonas; some vaccine-producing strains have been reported to be 693 
stable for up to 20 months; therefore the cost is reduced by eliminating extraction and 694 
purification steps (Specht and Mayfield, 2014). Algal-based recombinant vaccines administered 695 
orally as dry biomass have demonstrated effectiveness in two studies, namely protection against 696 
Staphylococcus aureus infection (Dreesen et al., 2010) and a potential malaria vaccine (Gregory 697 
et al., 2013).  698 
 699 
The wet route for extraction offers the possibility of recovery of recombinant proteins with high 700 
purity. However, cell disruption techniques can be limited since the proteins of interest can be 701 
compromised during harsh conditions. Cell lysis can be accomplished by combining 702 
mechanical, physical and chemical methods. The most common methods are freezing, 703 
sonication and lysis with a buffer, and any combination of them will result in a disrupted 704 
concentrate that must go through more purification steps. Cell disruption methods adopted by 705 
the community vary considerably, some common approaches are: freezing followed by lysis 706 
buffer (Gregory et al., 2013), and lysis buffer coupled with sonication (Demurtas et al., 2013; 707 
Rasala et al., 2012). 708 
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 709 
There is an alternative third route in the process, termed the “supernatant route”. This route is 710 
only possible when nuclear-expressed proteins are coupled with a signal peptide in order to be 711 
secreted into the culture media and thereby facilitate product recovery (Table 4). After 712 
cultivation, biomass is discarded as the recombinant proteins are present in the media. The 713 
proteins are then concentrated by filtration, lyophilisation or precipitation and further purified. 714 
Lauersen et al. (2015) optimized culture conditions and parameters of an engineered 715 
Chlamydomonas strain able to secrete an ice-binding protein with potential use in the food 716 
industry; they found that photomixotrophic cultivations led to accumulation of ∼10 mg L−1 of 717 
this protein in a small scale. Larger scale experiments (10 L) conducted in plastic bags under the 718 
same conditions resulted in ∼12 mg L−1 of recombinant protein accumulated in the medium. 719 
Compared with other microbial systems where secretion of recombinants proteins into the 720 
culture media is well established, microalgae still needs further develop and optimization in 721 
order to have comparable secretion yields. 722 
 723 
Thus, although microalgae appear to be an attractive platform for biomanufacturing of high 724 
value proteins for industrial, nutritional and medical uses, downstream operations have 725 
technical challenges and such processes are still limited to small-scale proof of concept studies. 726 
On the other hand, the high cost of downstream processing of high value products from 727 
transgenic algae can be avoided in applications where no product purification is required, thus 728 
resulting in less expensive processing. The next step is to explore higher scale production levels 729 
in order to make the platforms competitive with other expression platforms. The first (and so far 730 
only) example of large-scale production of an algal-expressed therapeutic protein was MAA in a 731 
volume of 100 L in a greenhouse (Gimpel et al., 2014).  732 
 733 
8. Conclusions 734 
 735 
In this review we have highlighted the biotechnological potential of microalgae from several 736 
different angles. Microalgae are a valuable source of natural products, including carotenoids, 737 
antioxidants and pigments, in addition to being used as feed stock or for the production of 738 
biodiesel. Advances in genetic engineering also mean that some species can be transformed and 739 
used as cell factories for other high-value products, including recombinant proteins. Several 740 
vaccine antigens, antibodies and some enzymes have now been produced in the model alga C. 741 
reinhardtii. In addition, efforts have been directed towards metabolic engineering in algae and 742 
cyanobacteria. On a different note, we have also summarised the current research into 743 
engineering algal communities and the potential benefit of co-culturing bacteria and algae to 744 
increase productivity, reduce energy inputs and protect cultures from pathogens. Considering 745 
these aspects, the great potential of microalgae in biotechnology becomes evident. However, 746 
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large-scale production remains a challenge and microalgae still struggle to compete with 747 
existing platforms. It remains to be seen whether microalgae will be used for a wide range of 748 
industrial applications or only for more specialised applications, where there are severe 749 
shortcomings in competing platforms. The niche for microalgae still needs to be developed. The 750 
GRAS status of many microalgae, their inexpensive culturing and potential for large-scale 751 
growth in bioreactors are definitely distinctive advantages of these photosynthetic 752 
microorganisms and upcoming years will reveal where the industry is headed. 753 
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12. Tables 
 
Table 1 DNA delivery methods for Chlamydomonas reinhardtii and Phaeodactylum tricornutum  
 
Organelle Species Delivery Methods References 
Nucleus Chlamydomonas 
reinhardtii 
Microparticle bombardment, 
electroporation, Agrobacterium 
tumefaciens, glass beads, silicon 
carbide whiskers and aminoclay 
nanoparticles 
Boynton et al., 1988; 
Brown et al., 1991; 
Dunahay, 1993; Kim et 
al., 2014; Kindle, 1990; 
Kumar et al., 2004 
Nucleus Phaeodactylum 
tricornutum 
Microparticle bombardment, 
electroporation 
Apt et al., 1996; 
Falciatore et al., 1999 
Miyahara et al., 2013; 
Zhang and Hu, 2014  
Chloroplast Chlamydomonas 
reinhardtii 
Microparticle bombardment, glass 
beads  
Boynton et al., 1988 
Kindle et al., 1991 
Chloroplast Phaeodactylum 
tricornutum 
Electroporation Xie et al., 2014 
Mitochondria Chlamydomonas 
reinhardtii 
Microparticle bombardment Randolph-Anderson et 
al., 1993 
  
  38 
Table 2 Common marker and reporter genes used in Chlamydomonas reinhardtii and 
Phaeodactylum tricornutum  
 
Species Marker/Reporter 
Genes 
Description Reference 
C
h
la
m
yd
o
m
o
n
a
s 
re
in
h
a
rd
ti
i 
Marker Genes 
Chloroplast 
atpB 
 
psbH  
 
 
Nucleus 
ARG7 
 
NIT1 
 
ble 
 
 
aadA 
 
 
aph7” 
 
 
bptII  
 
aphVIII  
 
 
 
als  
 
 
cry1-1  
 
 
oee-1  
 
cat 
 
 
ATP synthase subunit 
 
Thylakoid membrane protein (PSII subunit) 
 
 
 
Argininosuccinate lyase 
 
Nitrate reductase 
 
Protein conferring resistance to bleomycin, 
phleomycin and zeomycin 
 
Adenylyl transferase (resistance to 
spectinomycin) 
 
Streptomyces hygroscopicus aminoglycoside 
phosphotransferase  
 
Neomycin phosphotransferase III 
 
Aminoglycoside 3’phosphotransferase 
(resistance to paromomycin, kanamycin and 
neomycin) 
 
Acetolactate synthase (resistance to 
sulphonylurea herbicides) 
 
Ribosomal protein S14 
 
 
Oxygen evolving enhance protein  
 
Chloramphenicol acetyltransferase (resistance 
to chloramphenicol)  
 
Boynton et al., 1988 
                                  
Cullen et al., 2007 
 
Debuchy et al., 1989                                                 
Kindle et al. (1989) 
                                     
Stevens et al., 1996      
                                          
Goldschmidt-Clermont, 
1991                                                     
                             
Berthold et al., 2002 
                                        
Hall et al., 1993 
                                    
Sizova et al., 1996 
 
Kovar et al., 2002 
                                 
Nelson and Lefebvre, 
1995 
Chang et al., 2003 
 
Tang et al., 1995 
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Reporter genes 
gus 
gfp 
luc  
chgfp  
ars 
 
β-Glucuronidase 
Green fluorescent protein  
Luciferase 
Modified green fluorescent protein  
Arylsulphatase 
 
Kumar et al., 2004 
Kumar et al., 2004 
Fuhrmann et al., 2004 
Fuhrmann et al., 1999 
Davies et al., 1992 
 
P
h
a
eo
d
a
ct
yl
u
m
 t
ri
co
rn
u
tu
m
 
Marker genes 
Chloroplast 
cat 
 
Nuclear 
ble 
nptII 
hpt  
nat/sat1  
cat 
 
 
Chloramphenicol acetyltransferase 
 
 
Resistance to bleomycin, phleomycin and 
zeomycin 
Neomycin phosphotransferase III 
Hygromycin B phosphotransferase  
Nourseothricin resistance 
Chloroamphenicol acetyltransferase (resistance 
to chloroamphenicol)  
 
 
Xie et al. 2014 
 
 
(Apt et al., 1996; 
Zaslavskaia et al., 2001)  
 
Reporter genes 
egfp  
glut1 
hup1 
 
Modified green fluorescent protein 
Glucose Transporter  
Hexose Transporter 
 
(Zaslavskaia et al., 2001; 
2000) 
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Table 3 Key benefits of engineering algal communities for biotechnological exploitation. 
 
Benefit Reasoning  Reference 
Improved algal 
productivity  
Resource-use complementarity is when algal species with 
different growth requirements are grown together; the 
competition for resources between the organisms is lowered 
allowing the individual species to cohabit thus increasing net 
biomass of the culture.  
(Kazamia et al., 
2014; Nalley et 
al., 2014 and 
Smith and 
Crews 2014) 
Enhanced crop 
protection  
The competitive exclusion principle is when a culture contains 
a diverse array of organisms. Resources or niches are therefore 
occupied leading to an increased ability to competitively 
exclude invaders.  
(Kazamia et al., 
2012; Nalley et 
al., 2014 and 
Smith and 
Crews 2014) 
Reduction of 
energy inputs 
The use of organisms to provide scarce or expensive resources 
such as vitamin B12 or fixed nitrogen into the media.  
(Kazamia et al., 
2014 and Ortiz-
Marquez et al., 
2013)  
Increased 
stability and 
resilience 
Stability of communities can be defined as the minimal 
population fluctuation despite a disturbance and resilience can 
be defined as the ability for a community to revive after a 
disturbance. Increasing algal diversity and richness has been 
shown to improve the stability and resilience of algal cultures.  
(Nalley et al., 
2014)  
Increasingly 
broad and 
complex 
engineering of 
metabolic 
pathways 
Microbial communities engineered to produce valuable 
products have many advantages due to the division of labour. 
The ability to compartmentalise complex pathways into a 
number of strains could lead to optimised functionality and 
lowering metabolic burden on any one cell.  
(Jagmann and 
Phillip 2014) 
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Table 4. Secretion of recombinant proteins from Chlamydomonas reinhardtii  
 
Signal peptide  Protein secreted  Reference 
Arylsulphatase (ARS2)  Luciferase and erythropoietin Eichler-Stahlberg et al., 2009 
POXA1b (from Pleurotus 
ostreatus) 
Laccase Chiaiese et al., 2011 
Arylsulphatase (ARS1) Xylanase Rasala et al., 2012 
carbonic anhydrase 1 (CAH1) Gaussia luciferase Lauersen et al., 2013a 
Luciferase Luciferase Ruecker et al., 2008 
Carbonic anhydrase 1 
(CAH1) 
Ice-binding protein Lauersen et al., 2013b 
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13. Figure legends 
 
Figure 1: Relocation of Cytochrome P450s from the Endoplasmic Reticulum (ER) into the 
thylakoid membranes for coupling with photosynthetic electron flow. Most cytochromes P450 
function in the endoplasmic reticulum where they interact with specific enzymes (cytochrome P450 
reductases) that provide the reducing power to drive complex substrate modifications. It has now been 
shown that these key enzymes can be expressed in the chloroplasts of plants, algae and cyanobacteria, 
where the P450s are active and able to use reducing power from ferredoxin. This provides a novel 
route for the formation of complex metabolites involving P450 enzymes. 
 
 
Figure 2. Downstream processing of recombinant proteins extracted from transgenic algae 
systems. The Figure shows a flow-chart for the downstream processing of algal extracts by the ‘dry 
route’ involving freeze-drying or the ‘wet route’ involving cell disruption and fractionation. 
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